{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380004235794584207.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Y. Kojima"}],"foaf:familyName":[{"@value":"Kojima"}],"foaf:givenName":[{"@value":"Y."}]}],"career":[{"institution":{"notation":[{"@value":"Department of Gastroenterology and Hepatology Ise Red Cross Hospital  Ise Japan"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360004235794584192","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1111/jvh.12691"},{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.12691"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.12691"},{"@type":"PMID","@value":"28199034"}],"notation":[{"@value":"Hepatitis B surface antigen reduction by switching from long‐term nucleoside/nucleotide analogue administration to pegylated interferon"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/jvh.12691_BvAZo4s1ODsnd0ub2SbmM5iEeut"},{"@type":"OPENAIRE","@value":"doi_dedup___::ad78643508e3d46ca52b04c6e6ec50af_BvAZo4s1ODsnd0ub2SbmM5iEeut"}]}